New rare genetic variants are linked to ALS, expanding understanding of genetic contributors. About a quarter of ALS cases have an identifiable genetic contributor. Findings support broader use of ...
Columbia's Silence ALS program is testing spinal antisense therapy in a high‑risk patient; early EMG tests normalized.
A scientist diagnosed with an ultra-rare form of ALS linked to a CHCHD10 gene mutation is now enrolled in a one-of-a-kind ...
Every few months for the past three years, Jeff Vierstra has been receiving infusions in his spine that target and disable a ...
A medical student at the University of Pennsylvania is on a special mission in the research lab that could save her life. Yentli Soto Albrecht's battle is against ALS, a fatal neurodegenerative ...